154 related articles for article (PubMed ID: 11530807)
1. Myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of Vater.
Takahashi T; Kazama Y; Shimizu H; Yoshimoto M; Tsujisaki M; Aoki S; Imai K
Int J Hematol; 2001 Jul; 74(1):64-9. PubMed ID: 11530807
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
Saito K; Nakamura Y; Aoyagi M; Waga K; Yamamoto K; Aoyagi A; Inoue F; Nakamura Y; Arai Y; Tadokoro J; Handa T; Tsurumi S; Arai H; Kawagoe Y; Gunnji H; Kitsukawa Y; Takahashi W; Furusawa S
Int J Hematol; 2000 Apr; 71(3):238-44. PubMed ID: 10846828
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Efficacy of Low-dose Decitabine Combined with CAG Regimen in Patients with Myelodysplastic Syndrome-refractory Anemia with Excess Blasts(MDS-RAEB)].
Wang M; Han HH; Guo R; Liu YF; Jiang ZX; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1482-1486. PubMed ID: 29070129
[TBL] [Abstract][Full Text] [Related]
4. Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.
Li JM; Shen Y; Wu DP; Liang H; Jin J; Chen FY; Song YP; Song EY; Qiu XF; Hou M; Qiu ZC; Shen ZX
Int J Hematol; 2005 Jul; 82(1):48-54. PubMed ID: 16105759
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
[TBL] [Abstract][Full Text] [Related]
6. Remission induction of refractory anaemia with excess blasts in transformation by sole treatment with granulocyte colony-stimulating factor with persistent chromosomal abnormality.
Kondo H; Kasahara Y; Mori A
Acta Haematol; 2002; 107(3):177-81. PubMed ID: 11978940
[TBL] [Abstract][Full Text] [Related]
7. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
8. [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia].
Yamato H; Yamada K; Koike T; Yoshida M; Tsunogake S; Aoyagi M; Nakamura Y; Watanabe K; Saito K; Enokihara H
Rinsho Ketsueki; 1995 Feb; 36(2):128-33. PubMed ID: 7536277
[TBL] [Abstract][Full Text] [Related]
9. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
[TBL] [Abstract][Full Text] [Related]
10. Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.
Michels SD; Saumur J; Arthur DC; Robison LL; Brunning RD
Cancer; 1989 Dec; 64(11):2340-6. PubMed ID: 2804925
[TBL] [Abstract][Full Text] [Related]
11. A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
Jackson G; Taylor P; Smith GM; Marcus R; Smith A; Chu P; Littlewood TJ; Duncombe A; Hutchinson M; Mehta AB; Johnson SA; Carey P; MacKie MJ; Ganly PS; Turner GE; Deane M; Schey S; Brookes J; Tollerfield SM; Wilson MP
Br J Haematol; 2001 Jan; 112(1):127-37. PubMed ID: 11167793
[TBL] [Abstract][Full Text] [Related]
12. Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
Duell T; Poleck-Dehlin B; Schmid C; Wunderlich B; Ledderose G; Mittermuller J; Kolb HJ; Schmetzer H
Acta Haematol; 2006; 116(2):131-6. PubMed ID: 16914909
[TBL] [Abstract][Full Text] [Related]
13. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.
Hirono S; Tani M; Terasawa H; Kawai M; Ina S; Uchiyama K; Nakamura Y; Kakudo K; Yamaue H
Hepatogastroenterology; 2008; 55(84):861-4. PubMed ID: 18705284
[TBL] [Abstract][Full Text] [Related]
14. Duplication of 1q in a child with down syndrome and myelodysplastic syndrome.
Blann MM; Morgan DL; Oblender M; Heinen B; Williams J; Tonk VS
Cancer Genet Cytogenet; 2000 May; 119(1):74-6. PubMed ID: 10812176
[TBL] [Abstract][Full Text] [Related]
15. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
16. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
17. Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.
Sato N; Nakazato T; Kizaki M; Ikeda Y; Okamoto S
Int J Hematol; 2004 Feb; 79(2):147-51. PubMed ID: 15005342
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.
Breccia M; Petti MC; D'Elia GM; D'Andrea M; Carmosino I; Alimena G
Eur J Haematol; 2002 Jan; 68(1):1-3. PubMed ID: 11952816
[TBL] [Abstract][Full Text] [Related]
19. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Kawakami K; Watanabe Y; Kadowaki S
Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
